ARCTURUS THERAPEUTICS HOLDINGS INC. Long-Term Debt
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Long-Term Debt of $15.00 million as of 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2025-05-12
- 2025-03-31: Long-term Debt, Excluding Current Maturities $15.00M.
- 2023-09-30: Long-term Debt, Excluding Current Maturities $20.00M.
- 2022-09-30: Long-term Debt, Excluding Current Maturities $32.04M.
- 2022-06-30: Long-term Debt, Excluding Current Maturities $35.76M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2025-03-31 | $15.00M 10-Q · filed 2025-05-12 |
| 2023-09-30 | $20.00M 10-Q · filed 2023-11-14 |
| 2022-09-30 | $32.04M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $35.76M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $39.23M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $40.63M 10-K · filed 2023-03-29 |
| 2021-09-30 | $42.34M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $56.31M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $58.15M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $13.85M 10-K · filed 2022-03-01 |
| 2020-09-30 | $15.08M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $15.06M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $15.03M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $14.99M 10-K · filed 2021-03-01 |
| 2019-09-30 | $10.02M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $9.98M 10-Q · filed 2019-08-14 |
| 2018-12-31 | $9.91M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |